Beyond GLP ‐1

Journal of Diabetes · Published 2026-02-01 · DOI 10.1111/1753-0407.70204

Free full text

Authors being retrieved — see the publisher record. https://doi.org/10.1111/1753-0407.70204

Abstract

DOAJ holds no abstract for this record.

Read the article at the publisher →

Publication details

Year

2026

Related articles

• Blood Pressure Status Modulates the Therapeutic Response to Sodium‐Glucose Cotransporter 2 Inhibitors in Diabetic Macular Edema: A Post Hoc Subgroup Analysis of the COMET Trial · Journal of Diabetes · 2025 · Same journal
• November 11–12, 2025, T1DX‐QI Learning Session, Journal of Diabetes · Journal of Diabetes · 2026 · Same journal
• Multimorbidity between Type 2 Diabetes and Depressive Symptoms in Mexico: Prevalence and Associated Factors From the Nationally Representative ENSANUT 2022 Survey · Journal of Diabetes · 2026 · Same journal
• Effect of Topical Application of Antimicrobial Peptide PL ‐5 (Peceleganan) Spray on Mild to Moderate Infection of Diabetic Foot Ulcers: A Multicenter, Randomized, Double‐Blinded, Placebo‐Controlled Clinical Trial · Journal of Diabetes · 2026 · Same journal
• Efficacy and Safety of Glimepiride, Voglibose, and Metformin ER in Type 2 Diabetes: A Randomized, Active‐Controlled Study · Journal of Diabetes · 2026 · Same journal
• Delphi Consensus on the Use of Fenofibrate as Systemic Therapy for the Prevention of Diabetic Retinopathy Progression · Journal of Diabetes · 2026 · Same journal
• Diabetes and the Retina: The Role of Medical Treatment · Journal of Diabetes · 2025 · Same journal
• Mitochondrial Homeostasis in Pancreatic β Cell Function: Mechanisms and Therapeutic Targets for Diabetes · Journal of Diabetes · 2026 · Same journal
• Updates in Type 1 Diabetes ( T1D ): What Recent Findings Might Mean for Treatment and Prevention Strategies · Journal of Diabetes · 2026 · Same journal
• Impact of Imatinib Therapy on Immunometabolism to Promote β‐Cell Survival in Diabetes · Journal of Diabetes · 2026 · Same journal